Cyclerion Therapeutics, Inc.
CYCN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$976 | -$324 | -$1,429 | $530 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $114 | $122 |
| Change in WC | $594 | -$293 | $347 | -$292 |
| Other Non-Cash | $118 | $114 | $0 | $0 |
| Operating Cash Flow | -$264 | -$503 | -$968 | $360 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1,826 | -$130 | $1,375 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $1,826 | -$130 | $1,375 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $1,562 | -$633 | $407 | $360 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,006 | $3,639 | $3,232 | $2,872 |
| End Cash | $4,568 | $3,006 | $3,639 | $3,232 |
| Free Cash Flow | -$264 | -$503 | -$968 | $360 |